Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This Special Issue is dedicated to neuroendocrine neoplasms (NENs), a category of malignancy that demonstrates wide clinical heterogeneity, posing major challenges in diagnosis and management. There have been significant advances in the field of NEN genomics, pathology, imaging, and treatment over the past five years. NENs are examples of rare tumours (although their incidence and prevalence are increasing) where international collaborative efforts have allowed the generation of high-level evidence to guide optimal patient-centred care. This issue presents both reviews and original papers to provide comprehensive state-of-the-art understanding of this fascinating disease.

Medicine --- small bowel neuroendocrine tumours --- pancreatic neuroendocrine tumours --- liver metastases --- midgut --- meta-analysis --- neuroendocrine tumors --- carcinoid heart disease --- carcinoid syndrome --- somatostatin analogues --- metastases --- multidisciplinary --- management --- outcome --- grading --- staging --- neuroendocrine neoplasms --- chemotherapy --- temozolomide --- metronomic treatment --- second-line --- NOTCH --- cancer-driven genes --- mutational mechanism --- germline mutations --- small cell lung carcinoma --- pancreatic NET --- small bowel NET --- medullary thyroid carcinoma --- malignant castration-resistant prostatic cells --- quality performance indicators --- QPIs --- cancer care --- neuroendocrine tumour --- NETs --- modified Delphi --- CommNETs --- pancreatic neuroendocrine neoplasms --- neuroendocrine tumor --- long-term functional outcomes --- pancreatectomy --- diabetes mellitus --- pancreatic exocrine insufficiency --- body mass index --- parenchyma-sparing surgery --- neuroendocrine tumours --- curative surgery --- resection --- follow-up --- guidelines --- relapse --- recurrence --- risk factor --- mixed non-neuroendocrine neuroendocrine neoplasms --- MiNENs --- mixed adeno-neuroendocrine carcinoma --- MANEC --- 2017 WHO classification --- 2019 WHO classification

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Breast cancer is acknowledged as an international priority in healthcare. It is currently the most common cancer in women worldwide, with demographic trends indicating a continuous increase in incidence. Over the years, increasing efforts and resources have been devoted to the search for a systematic and optimized strategy in breast cancer diagnosis and treatment. Today, the Breast Unit model is considered the gold standard in order to ensure optimal patient-centered and research-based clinical services through multidisciplinary and integrated management.Surgical treatment has gradually evolved toward less aggressive approaches with the adoption of new therapeutic strategies. The evolution of evidence-based guidelines in such leading disciplines as radiation and medical oncology has led to a steady improvement in survival rates. This Special Issue will highlight innovations in the integrated management of breast cancer, their potential advantages, and the many open issues that still need to be properly defined and addressed.

Medicine --- Pharmacology --- metastatic breast cancer --- breast surgery --- immune system --- metabolic derangements --- precision medicine --- integrated therapies --- advanced breast cancer --- mTOR inhibitor --- CDK4/6 inhibitor --- endocrine resistance --- breast cancer --- pregnancy --- chemotherapy --- tailoring --- personalization --- DataMart --- real world data --- predictive model --- healthcare --- breast-conserving surgery --- non-palpable breast lesions --- image-guided localization --- preoperative breast localization --- breast ultrasound --- large database --- standardized data collection --- networks --- nipple-sparing mastectomy --- immediate breast reconstruction --- acellular dermal matrix (ADM) --- aesthetic and oncological outcomes --- quality of life --- rare breast cancer --- osteoclast-like giant cells --- gene profiling --- Oncotype Dx --- adjuvant treatment --- neoadjuvant chemotherapy --- sentinel lymph node --- systemic treatment --- locally advanced breast cancer --- mini-invasive treatment --- liver metastases --- hepatic surgery --- personalized medicine --- sarcopenia --- physical performance --- frailty --- older cancer patients --- clinical trial --- patient enrollment --- artificial intelligence --- machine learning --- lung cancer --- oncology --- web app --- conventional CT and CT angiography --- DIEP flap planning --- multidisciplinary treatment --- evidence-based medicine --- personalized treatment --- oncological outcomes --- patient quality of life --- normal breast --- breast pathology --- hormone receptor --- hormone expression --- lymphedema --- lymphaticovenous anastomosis --- vascularized lymph node transfer --- lymphatic microsurgery --- radiotherapy --- oligometastatic breast cancer --- locoregional therapy --- CDK4/6 inhibitors --- multidisciplinary --- AMH --- ovarian reserve --- pregnancy desire --- subtypes breast cancer --- miRNAs --- breast cancer treatment --- next-generation-sequencing --- target therapy --- old age --- survival --- vitamin D --- ductal breast cancer --- in situ breast cancer --- lobular breast cancer --- histology

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Minimally invasive surgery has become a common term in visceral as well as gynecologic surgery. It has almost evolved into its own surgical speciality over the past 20 years. Today, being firmly established in every subspeciality of visceral surgery, it is now no longer a distinct skillset, but a fixed part of the armamentarium of surgical options available. In every indication, the advantages of a minimally invasive approach include reduced intraoperative blood loss, less postoperative pain, and shorter rehabilitation times, as well as a marked reduction of overall and surgical postoperative morbidity. In the advent of modern oncologic treatment algorithms, these effects not only lower the immediate impact that an operation has on the patient, but also become important key steps in reducing the side-effects of surgery. Thus, they enable surgery to become a module in modern multi-disciplinary cancer treatment, which blends into multimodular treatment options at different times and prolongs and widens the possibilities available to cancer patients. In this quickly changing environment, the requirement to learn and refine not only open surgical but also different minimally invasive techniques on high levels deeply impact modern surgical training pathways. The use of modern elearning tools and new and praxis-based surgical training possibilities have been readily integrated into modern surgical education,which persists throughout the whole surgical career of modern gynecologic and visceral surgery specialists.

Medicine --- ovarian cancer --- laparoscopy --- minimally invasive surgery --- survival --- mortality --- platelet-rich plasma (PRP) --- thin endometrium --- hysteroscopy --- robotic surgery --- sexuality --- laparoscopic hysterectomy --- learning curve --- quality of life --- counseling --- patient-doctor-relationship --- body donors --- surgical education --- clinical anatomy --- live surgery events --- neuropelveology --- LION procedure --- genital nerves stimulation --- chronic pelvic pain --- esophagectomy --- esophageal cancer --- Ivor-Lewis procedure --- health-related quality of life --- cervical cancer --- robotic radical hysterectomy --- recurrence rate --- surgery --- artificial intelligence --- machine learning --- augmented reality --- hysterectomy --- NOTES --- minimally invasive --- systematic review --- meta-analysis --- pediatric surgery --- fetal surgery --- single-incision surgery --- surgical techniques --- surgical devices --- open surgery --- endoscopy --- endoscopic surgery --- cysts of the canal of Nuck --- Nuck hydrocele --- hydrocelectomy --- TAPP --- Lichtenstein --- colorectal liver metastases --- laparoscopic liver surgery --- minimal invasive surgery --- general anesthesia --- anesthetics --- perioperative care --- laparoscopic surgery --- endometrial cancer --- lymphadenectomy --- embryology --- sentinel lymph node mapping --- indocyanine green --- PMMR --- technical aspects --- rectal cancer --- mesorectal --- transanal --- laparoscopic --- local recurrence --- conversion rate --- minimally invasive surgical procedures --- radiotherapy --- ovarian neoplasms --- endometrial neoplasms --- uterine cervical neoplasms --- vaginal neoplasms --- vulvar neoplasms --- survival analysis --- video feedback --- video modeling --- gynecology --- surgical training --- pelvitrainer --- prolapse --- pelvic floor --- native tissue --- pectopexy --- robotic assisted surgery --- pancreatic surgery --- pancreaticoduodenectomy --- pelvic floor repair --- laparoscopic repair --- vaginal repair --- mesh use --- VATS --- pain --- postoperative pain control --- thoracic surgery --- lung cancer --- intercostal catheter --- opioid --- regional anaesthesia --- hepatectomy --- single-port laparoscopy --- radiofrequency pre-coagulation --- endometriosis --- endometrioma surgery --- ovarian reserve --- anti-Müllerian hormone --- spontaneous pregnancy --- robotic liver resection --- da Vinci --- intraoperative imaging --- hepatocellular cancer --- real-life imaging --- hepatic metastasis --- COVID-19 --- sars-cov-2 --- surgical performance --- 3D printing --- skill assessment --- snorkel mask --- malabsorption --- Roux-en-Y gastric bypass --- one-anastomosis gastric bypass --- SADI-S --- biliopancreatic diversion --- weight regain --- hepatocellular carcinoma --- cholangiocarcinoma --- risk score --- pelvic compartments --- embryologic development --- oncologic surgery --- pelvic lymphonodectomy --- topographic anatomy --- autonomic pelvic nerves --- uterine cancer --- prostate cancer --- diaphragmatic hernia --- liver resection --- hernia repair --- mesh --- enterothorax